The DOI matches its Crossref record; the references it cites are not checked yet.
The Metabolic Derangements and Treatment of Diabetic Ketoacidosis
Abstract
Diabetic ketoacidosis is a common illness among patients with diabetes. The exact prevalence is unknown, but in one community the rate was estimated to be 13.4 episodes per 1000 patient-years in young persons with diabetes.1 It remains a serious event, with mortality rates as high as 6 to 10 per cent.2 , 3 In children under 10 years of age, diabetic ketoacidosis accounts for 70 per cent of diabetes-related deaths.4 Death may be due to derangements that are directly attributable to ketoacidosis, to complications associated with the illness itself, or to abnormalities induced by treatment. Because a substantial percentage of deaths is . . .
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Large, randomized trials have shown that participants with established T2D and a history of 1 or more severe hypoglycemic events had an approximately 2- to 4-fold higher rate of mortality for reasons that remain unknown.87,1110”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [1110]
In the citing paper
“In the ADVANCE trial, severe hypoglycemia was associated with significant risk increases for CV events including death.1110”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [1110]
Citations
The citation lists are queued
They are fetched later and appear here then.
References 87 · Cited by 318
Research works printed but not linked: 8
- Johnson, 1980, Mayo Clin Proc, 55, 83
- Exton JH. The effects of glucagon on hepatic glycogen metabolism and gluconeogenesis. In: Unger RH, Orci L, eds. Glucagon: physiology, pathophysiology, and morphology of the pancreatic A-cells. New York: Elsevier/North Holland, 1981:195–219.
- Verdon, 1981, Bull Eur Physiopathol Respir, 17, 223
- Foster, 1974, Adv Intern Med, 19, 159
- Foster DW. Diabetes mellitus. In: Petersdorf RG, Adams RD, Braunwald E, Isselbacher KJ, Martin JB, Wilson JD, eds. Harrison's principles of internal medicine. 10th ed. New York: McGraw-Hill, 1983:661–79.
- 10.1001/archinte.1981.00340060021006 · doi:10.1001/archinte.1981.00340060021006
- 10.1001/archinte.1982.00340160097021 · doi:10.1001/archinte.1982.00340160097021
- Matz, 1976, NY State J Med, 76, 1299
Metadata
- Authors
- Flier, J. S., Moore, M. J., Foster, D. W., & McGarry, J. D.
- Affiliations
- The University of Texas Southwestern Medical Center (US)
- University of Texas Health Science Center at Dallas (US)
- ORCID
- Flier, Jeffrey S.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 1983-07-21
- Volume
- 309
- Issue
- 3
- Pages
- 159-169
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2017127800
- Cited by
- 318
- References
- 87
- Citations by year
- 2025: 3 · 2024: 4 · 2023: 9 · 2022: 8 · 2021: 11 · 2020: 12 · 2019: 8 · 2018: 6 · 2017: 6 · 2016: 7 · 2015: 11 · 2014: 6 · 2013: 9 · 2012: 8
- FWCI
- 1.64
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
- Keywords
- diabetic ketoacidosis, metabolic disorders, diabetes mellitus, mortality, children, prevalence
- MeSH terms
- Bicarbonates, Brain Edema, Fluid Therapy, Glucose, Humans, Infections, Insulin, Insulin Resistance, Ketones, Phosphates, Potassium, Shock, Thrombosis, Diabetic Ketoacidosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Metabolic Derangements and Treatment of Diabetic Ketoacidosis. https://app.cochat.ai/papers/10.1056/nejm198307213090307
- The paper
- Flier, J. S., Moore, M. J., Foster, D. W., & McGarry, J. D. (1983). The Metabolic Derangements and Treatment of Diabetic Ketoacidosis. New England Journal of Medicine. https://doi.org/10.1056/nejm198307213090307
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.